<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Chromosome 1 pericentromeric heterochromatin (1q) has been shown to play an important role in the pathogenesis of non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) results from marrow failure in two or more cell lineages </plain></SENT>
<SENT sid="2" pm="."><plain>Although <z:mp ids='MP_0004027'>trisomy</z:mp> 1q has been reported in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, it is usually present with additional common abnormalities such as <z:mp ids='MP_0004027'>trisomy</z:mp> 8, <z:mp ids='MP_0004026'>monosomy</z:mp> 5 or <z:mp ids='MP_0004026'>monosomy</z:mp> 7, leading to speculation that 1q abnormalities are mostly secondary events representing <z:e sem="disease" ids="C1516669" disease_type="Neoplastic Process" abbrv="">clonal evolution</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We report two cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> in which consistent involvement of 1q heterochromatin is seen as the primary clonal abnormality </plain></SENT>
<SENT sid="4" pm="."><plain>Both patients presented with <z:mp ids='MP_0002899'>fatigue</z:mp> and <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Based on the published reports and our cases, we propose that the 1q heterochromatin plays a vital role in the pathophysiology of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Abnormalities involving 1q result in aberrant heterochromatin/euchromatin junctions, leading to gene dosage abnormalities </plain></SENT>
<SENT sid="7" pm="."><plain>Further studies of 1q abnormalities in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> might provide specific insights as to the exact role of the excess 1q heterochromatin in the etiology of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>